Business Wire

SunOpta Announces First Quarter 2022 Financial Results

Revenue growth of 15.7% vs prior year

Sequential revenue growth of 17.6% and gross profit growth of 52.1%

Strong quarterly year over year revenue, gross profit and EBITDA growth expected for the balance of the year

Major capacity expansion projects on track

MINNEAPOLIS--(BUSINESS WIRE)--SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a leading healthy food and beverage company focused on plant-based foods and beverages and fruit-based foods and beverages, today announced financial results for the first quarter ended April 2, 2022.


All amounts are expressed in U.S. dollars and results are reported in accordance with U.S. GAAP, except where specifically noted.

First quarter 2022 highlights:

  • Revenues of $240.2 million for the first quarter of 2022 increased 15.7% reflecting 13.4% growth in plant-based and 18.7% increase in fruit-based compared to the prior year
  • Gross margin decreased 270 basis points to 11.7% from 14.4% in the prior year, primarily reflecting inflationary factors impacting raw materials, freight, labor and utilities. Gross margin increased 270 basis points to 11.7% from 9.0% in the fourth quarter of 2021, reflecting increased production and pricing actions.
  • Net earnings from continuing operations were $0.7 million compared to $1.7 million in the prior year.
  • Adjusted earnings¹ attributable to common shareholders was $0.6 million or $0.01 per diluted common share in the first quarter of 2022, compared to earnings of $1.3 million or $0.01 per diluted common share in the first quarter of 2021.
  • Adjusted EBITDA¹ of $15.6 million, or 6.5% of revenues for the first quarter of 2022, was down 14.7% versus $18.3 million or 8.8% of revenues in the first quarter of 2021. Adjusted EBITDA increased 46% versus $10.7 million in the fourth quarter of 2021.

“We delivered strong first quarter results compared to Q4, reflecting significant progress on recent initiatives to enhance capacity and productivity coupled with robust demand across our portfolio. Plant-based revenue increased 13.4% on a year-over-year basis, driven by oat-based offerings up 59% and proprietary brands, with price and volume/mix both positive factors. The sharp recovery in our fruit-based business, where revenue increased 18.7%, was largely influenced by recent pricing actions as well as continued growth in fruit snacks and smoothie bowls,” said Joe Ennen, Chief Executive Officer. “While margins were below our year-earlier levels, we made significant progress from the fourth quarter of 2021, and believe that we have remedied production challenges in our plants and have passed on over 90% of inflationary pressures with price increases. I’m pleased to report that we are on track with expansion projects, including our new plant in Texas. This is a testimony to our focus on execution in this challenging environment. I’m also very proud of our recently released ESG report that outlines our framework around products, planet, people, and governance along with highlighting progress made in 2021. SunOpta is passionate about our commitments to sustainability as we continue to fuel the future of food. We remain highly confident in our strategic direction and growth outlook as well as our ability to create significant shareholder value.”

First Quarter 2022 Results

Revenues of $240.2 million for the first quarter of 2022 increased 15.7% compared to the first quarter of 2021 reflecting 13.4% growth in Plant-Based Foods and Beverages and 18.7% growth in Fruit-Based Foods and Beverages.

The Plant-Based Foods and Beverages segment generated revenues of $135.5 million during the first quarter of 2022, an increase of 13.4% compared to $119.5 million in the first quarter of 2021. Growth continued to be driven by oat-based offerings, reflecting pricing and volume/mix factors, along with incremental revenue from Dream and WestSoy.

The Fruit-Based Foods and Beverages segment generated revenues of $104.7 million during the first quarter of 2022, an increase of 18.7% compared to $88.2 million in the first quarter of 2021. Growth was driven by pricing and favorable volume/mix stemming from strong demand for fruit snacks, and one-time incremental volumes this quarter from one of our large frozen fruit customers, and the recent introduction of fruit smoothie bowls.

Gross profit was $28.0 million for the first quarter, a decrease of $2.0 million compared to $30.0 million in the prior year period. As a percentage of revenues, gross profit margin was 11.7% in the first quarter of 2022 compared to 14.4% in the first quarter of 2021, a decrease of 270 basis points. Gross profit in the Plant-Based Foods and Beverages segment decreased $3.2 million. The 470-basis point decrease in Plant-Based gross margin included an approximately 150 basis-point decline due to the dilutive effect of pass-through pricing to recover cost inflation on raw and packaging material. The remaining gross margin impact reflected unrecovered raw material and freight cost inflation, due to the lag in pricing adjustments, together with higher labor and utility rates, and increased depreciation expense, partially offset by volume growth and improved plant utilization. Gross profit in the Fruit-Based Foods and Beverages segment increased by $1.2 million. Gross margin was flat at 7.7%, despite an approximately 100 basis-point decline due to the dilutive effect of pass-through pricing to recover cost inflation on raw and packaging material. Excluding this pricing effect, fruit-based gross margin reflected the benefits of portfolio rationalizations for frozen fruit and manufacturing cost savings from the consolidation of our fruit processing facilities in 2021, partially offset by currently unrecovered freight and storage cost inflation, a higher mix of low-margin fruit juice sales, and frozen fruit inventory losses due to excess spoilage during handling.

Segment operating income¹ was $3.9 million, or 1.6% of revenues in the first quarter of 2022, compared to segment operating income of $6.1 million, or 2.9% of revenues in the first quarter of 2021. The decrease in segment operating income was due to lower gross profit, and increased SG&A mainly due to a special one-time bonus accrual of $1.6 million to reward employees for improved performance this quarter in our plants, partially offset by a reduction in variable stock-based compensation as the performance condition under the 2021 incentive plan was not achieved.

Adjusted EBITDA¹ was $15.6 million or 6.5% of revenues in the first quarter of 2022, compared to $18.3 million or 8.8% of revenues in the first quarter of 2021.

Earnings attributable to common shareholders for the first quarter of 2022 was $3.5 million, or $0.03 per diluted common share, compared to a loss of $0.3 million, or $0.00 per diluted common share during the first quarter of 2021.

Adjusted earnings¹ in the first quarter of 2022 was $0.6 million or $0.01 per common share, compared to adjusted earnings of $1.3 million or $0.01 per common share in the first quarter of 2021.

Please refer to the discussion and table below under “Non-GAAP Measures”.

Balance Sheet and Cash Flow

As of April 2, 2022, SunOpta had total assets of $785.8 million and total debt of $249.7 million compared to total assets of $755.1 million and total debt of $224.6 million at year end, 2021. During the first quarter of 2022, cash provided by operating activities of continuing operations was $15.5 million compared to cash used in operating activities of continuing operations of $7.0 million during the first quarter of 2021. Investing activities from continuing operations consumed $24.5 million of cash during the first quarter of 2022 versus $7.9 million in the prior year, primarily driven by the new plant in Midlothian, Texas which is expected to come online in late 2022.

2022 Outlook2

We are reaffirming our previously provided outlook for fiscal 2022, including:

Consolidated revenue range: $890 million - $930 million

Consolidated adjusted EBITDA1 range: $67 million - $75 million

Conference Call

SunOpta plans to host a conference call at 5:00 P.M. Eastern time on Wednesday, May 11, 2022, to discuss the first quarter financial results. After opening remarks, there will be a question and answer period. Investors interested in listening the live webcast can access a link on SunOpta's website at www.sunopta.com under the "Investor Relations" section or directly here. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company's website. This call may be accessed with the toll free dial-in number dial (888) 440-4182 or International dial-in number (646) 960-0653 using Conference ID: 8338433.

¹ See discussion of non-GAAP measures

2 The Company has included certain forward-looking statements about the future financial performance that include non-GAAP financial measures, including Adjusted EBITDA. These non–GAAP financial measures are derived by excluding certain amounts, expenses or income, from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts that are excluded from these non-GAAP financial measures is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period. We are unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures because management cannot reliably predict all of the necessary components of such GAAP measures. Historically, management has excluded the following items from certain of these non-GAAP measures, and such items may also be excluded in future periods and could be significant amounts.

  • Expenses related to the acquisition or divestiture of a business, including business development costs, impairment of assets, integration costs, severance, retention costs and transaction costs;
  • Start-up costs of new facilities and equipment;
  • Charges associated with restructuring and cost saving initiatives, including but not limited to asset impairments, accelerated depreciation, severance costs and lease abandonment charges;
  • Asset impairment charges and facility closure costs;
  • Legal settlements or awards; and
  • The tax effect of the above items.

About SunOpta Inc.

SunOpta (Nasdaq:STKL) (TSX:SOY) is a U.S.-based, global pioneer fueling the future of sustainable, plant-based and fruit-based food and beverages. Founded nearly 50 years ago, SunOpta manufactures natural, organic and specialty products sold through retail and foodservice channels. SunOpta operates as a manufacturer for leading natural and private label brands, and also proudly produces its own brands, including SOWN™, Dream™, West Life™ and Sunrise Growers™. For more information, visit www.sunopta.com and LinkedIn.

Forward-Looking Statements

Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, our expectation for quarterly year over year revenue, gross profit and EBITDA growth, our belief that we have remedied production challenges in our plants, our expectation that the Midlothian, Texas plant will come online in late 2022 and our previously provided outlook for consolidated revenues and adjusted EBITDA. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “expect”, “believe”, “continue”, “anticipate”, “estimates”, “can”, “will”, “target”, "should", "would", "plans", "becoming", "intend", "confident", "may", "project", "potential", "intention", "might", "predict", “budget”, “forecast” or other similar terms and phrases intended to identify these forward-looking statements. Forward-looking statements are based on information available to the Company on the date of this release and are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments including, but not limited to, the Company’s actual financial results; uninterrupted operations and service levels to our customers during COVID-19; inflationary factors impacting raw materials, freight, labor and utilities; current customer demand for the Company’s products and the additional anticipated demand due to COVID-19; general economic conditions; continued consumer interest in health and wellness; the Company’s ability to maintain or increase product pricing levels; potential shortages or inability to secure qualified labor personnel and construction supplies; planned facility and operational expansions, closures and divestitures; cost rationalization and product development initiatives; alternative potential uses for the Company’s capital resources; portfolio optimization and productivity efforts; the sustainability of the Company’s sales pipeline; the Company’s expectations regarding commodity pricing, margins and hedging results; improved availability and field prices for fruit; procurement and logistics savings; freight lane cost reductions; yield and throughput enhancements; and labor cost reductions. Whether actual timing and results will agree with expectations and predictions of the Company is subject to many risks and uncertainties including, but not limited to, potential loss of suppliers and customers as well as supply chain, logistics and other disruptions resulting from or related to COVID-19; unexpected issues or delays with the Company’s structural improvements and automation investments; failure or inability to implement portfolio changes, process improvements, go-to-market improvements and process sustainability strategies in a timely manner; changes in the level of capital investment; local and global political and economic conditions; consumer spending patterns and changes in market trends; decreases in customer demand; delayed or unsuccessful product development efforts; potential product recalls; working capital management; availability and pricing of raw materials and supplies; potential covenant breaches under the Company’s credit facilities; and other risks described from time to time under "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q (available at www.sec.gov). Consequently, all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The Company undertakes no obligation to publicly correct or update the forward-looking statements in this document, in other documents, or on its website to reflect future events or circumstances, except as may be required under applicable securities laws.

SunOpta Inc.

Consolidated Statements of Operations

For the quarters ended April 2, 2022 and April 3, 2021

(Unaudited)

(All dollar amounts expressed in thousands of U.S. dollars, except per share amounts)

 

 

 

 

 

 

 

 

 

 

Quarter ended

 

 

 

 

April 2, 2022

April 3, 2021

 

 

 

 

$

$

 

 

 

 

 

 

Revenues

240,173

 

207,640

 

 

 

 

 

 

 

Cost of goods sold

212,182

 

177,651

 

 

 

 

 

 

 

Gross profit

27,991

 

29,989

 

 

 

 

 

 

 

Selling, general and administrative expenses

21,935

 

20,874

 

Intangible asset amortization

2,612

 

2,194

 

Other expense, net

287

 

1,615

 

Foreign exchange loss (gain)

(472

)

836

 

 

 

 

 

 

 

Earnings from continuing operations before the following

3,629

 

4,470

 

 

 

 

 

 

 

Interest expense, net

2,530

 

1,660

 

 

 

 

 

 

 

Earnings from continuing operations before income taxes

1,099

 

2,810

 

 

 

 

 

 

 

Income tax expense

445

 

1,138

 

 

 

 

 

 

 

Earnings from continuing operations

654

 

1,672

 

Earnings from discontinued operations

3,566

 

-

 

Net earnings

4,220

 

1,672

 

 

 

 

 

 

 

Dividends and accretion on preferred stock

(755

)

(1,953

)

 

 

 

 

 

 

Earnings (loss) attributable to common shareholders

3,465

 

(281

)

 

 

 

 

 

 

Basic and diluted earnings (loss) per share

 

 

 

From continuing operations

(0.00

)

(0.00

)

 

From discontinued operations

0.03

 

-

 

Basic and diluted earnings (loss) per share

0.03

 

(0.00

)

 

 

 

 

 

 

Weighted-average common shares outstanding (000s)

 

 

 

Basic

107,399

 

96,120

 

 

Diluted

107,399

 

96,120

 

SunOpta Inc.

Consolidated Balance Sheets

As at April 2, 2022 and January 1, 2022

(Unaudited)

(All dollar amounts expressed in thousands of U.S. dollars)

 

 

 

 

 

 

 

 

 

 

April 2, 2022

January 1, 2022

 

 

 

 

$

$

 

 

 

 

 

 

ASSETS

 

 

Current assets

 

 

 

Cash and cash equivalents

495

 

227

 

 

Accounts receivable

98,220

 

84,702

 

 

Inventories

217,975

 

220,143

 

 

Prepaid expenses and other current assets

16,040

 

16,638

 

 

Income taxes recoverable

8,130

 

8,259

 

Total current assets

340,860

 

329,969

 

 

 

 

 

 

 

Property, plant and equipment, net

245,898

 

219,537

 

Operating lease right-of-use assets

43,174

 

47,245

 

Intangible assets, net

145,828

 

148,440

 

Goodwill

3,998

 

3,998

 

Other assets

6,057

 

5,930

 

 

 

 

 

 

 

Total assets

785,815

 

755,119

 

 

 

 

 

 

 

LIABILITIES

 

 

Current liabilities

 

 

 

Accounts payable and accrued liabilities

135,518

 

121,430

 

 

Current portion of long-term debt

17,864

 

9,760

 

 

Current portion of operating lease liabilities

10,104

 

12,203

 

Total current liabilities

163,486

 

143,393

 

 

 

 

 

 

 

Long-term debt

231,822

 

214,843

 

Operating lease liabilities

37,185

 

39,028

 

Long-term liabilities

4,034

 

2,241

 

Deferred income taxes

10,758

 

22,485

 

Total liabilities

447,285

 

421,990

 

 

 

 

 

 

 

Series B-1 preferred stock

28,291

 

28,145

 

 

 

 

 

  <

Back

Latest News

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.

Subscribe